Cerapedics Gains Breakthrough Device Designation for P-15L Bone Graft for the Treatment of Degenerative Disc Disease

Cerapedics P-15L Bone Graft

FDA granted Breakthrough Device designation for Cerapedics' investigational P-15L Bone Graft for the treatment of degenerative disc disease (DDD).

P-15L Bone Graft is currently being studied in the U.S. in ASPIRE, a prospective, single-blinded, multi-center, randomized, non-inferiority pivotal Investigational Device Exemption study to...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us